BioNxt Solutions Statistics
Total Valuation
BNXTF has a market cap or net worth of 38.27 million. The enterprise value is 42.26 million.
| Market Cap | 38.27M |
| Enterprise Value | 42.26M |
Important Dates
The last earnings date was Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +14.30% |
| Shares Change (QoQ) | +2.98% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 108.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,230.86 |
| PB Ratio | -7.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.81 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.15 |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.69 |
| Interest Coverage | -5.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -255.97% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 72.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.91% in the last 52 weeks. The beta is 1.61, so BNXTF's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +6.91% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 46.42 |
| Average Volume (20 Days) | 5,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BNXTF had revenue of 31,095 and -4.80 million in losses. Loss per share was -0.04.
| Revenue | 31,095 |
| Gross Profit | 31,095 |
| Operating Income | -3.96M |
| Pretax Income | -4.80M |
| Net Income | -4.80M |
| EBITDA | -3.90M |
| EBIT | -3.96M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 59,260 in cash and 4.16 million in debt, giving a net cash position of -4.10 million.
| Cash & Cash Equivalents | 59,260 |
| Total Debt | 4.16M |
| Net Cash | -4.10M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.47M |
| Book Value Per Share | -0.05 |
| Working Capital | -5.79M |
Cash Flow
In the last 12 months, operating cash flow was -2.40 million and capital expenditures -62,415, giving a free cash flow of -2.47 million.
| Operating Cash Flow | -2.40M |
| Capital Expenditures | -62,415 |
| Free Cash Flow | -2.47M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -12,733.95% |
| Pretax Margin | -15,422.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BNXTF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.30% |
| Shareholder Yield | -14.30% |
| Earnings Yield | -12.53% |
| FCF Yield | -6.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BNXTF has an Altman Z-Score of -159.51. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -159.51 |
| Piotroski F-Score | n/a |